Status:
COMPLETED
Short-time Intervention in Post-Covid Syndrome Syndrome (SIPCOV): A Pragmatic Randomised Controlled Trial
Lead Sponsor:
University Hospital, Akershus
Conditions:
COVID-19
Eligibility:
All Genders
16+ years
Phase:
NA
Brief Summary
The present study is a 2-arm pragmatic randomised controlled trial (RCT) in which 310 patients who suffer from post-Covid syndrome are randomised to either a short-time outpatient-based rehabilitation...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Fulfils pragmatic diagnostic criteria of idiopathic post-Covid syndrome: a) Confirmed acute Covid-19 by a positive PCR for SARS-CoV-2; b) Persistent symptoms at least 3 months following acute Covid-19 without symptom-free interval; c) Functional disability to an extent that interrupts all or a majority of normal activities (such as work/school attendance, physical exercise, social activities, etc.)
- Lives in one of the following Norwegian counties: Oslo, Viken, Innlandet, Vestfold og Telemark, Agder
- Informed consent to participation
- Exclusion criteria
- Other chronic illnesses or demanding life situations that might explain persistent symptoms and disability
- Sustained organ damage (lung, heart, brain) following acute, serious Covid-19
- Bedridden
- Insufficient command of Norwegian language
Exclusion
Key Trial Info
Start Date :
February 21 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 30 2024
Estimated Enrollment :
314 Patients enrolled
Trial Details
Trial ID
NCT05196451
Start Date
February 21 2022
End Date
April 30 2024
Last Update
May 30 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vegard Bratholm Wyller
Oslo, Norway, 1170